Neonatal bleeding and decreased plasma fibrinogen levels in mice modeled after the dysfibrinogen Vlissingen/Frankfurt IV
- 10 August 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8) , 1484-1487
- https://doi.org/10.1111/j.1538-7836.2004.00841.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Synthesis of a Mouse Model of the Dysfibrinogen Vlissingen/Frankfurt IVAnnals of the New York Academy of Sciences, 2006
- Fibrinogen Otsu I:A γ Asn319,Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant womanThrombosis and Haemostasis, 2003
- Molecular Mechanisms of Hypo‐ and AfibrinogenemiaAnnals of the New York Academy of Sciences, 2001
- A Novel Transgenic Mouse Model of HyperfibrinogenemiaThrombosis and Haemostasis, 2001
- A Functional Assay Suggests that Heterodimers Exist in Two C-Terminal γ-Chain Dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IVThrombosis and Haemostasis, 2000
- Hypofibrinogenemia Associated With a Heterozygous Missense Mutation γ153Cys to Arg (Matsumoto IV): In Vitro Expression Demonstrates Defective Secretion of the Variant FibrinogenBlood, 1999
- Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.Genes & Development, 1995
- Familial Dysfibrinogenemia and ThrombophiliaThrombosis and Haemostasis, 1995
- Nucleotide Sequences of the Three Genes Coding for Human FibrinogenPublished by Springer Nature ,1990
- Biosynthesis of Dog FibrinogenEuropean Journal of Biochemistry, 1982